Aurobindo Pharma524804Stake acquisition deal
Aurobindo's step-down arm A1 Biochem Labs allots shares and CCDs worth INR 33.80 crore, Apitoria stake down to 80%
80%Apitoria stake allotment
- Equity shares allotted
- 89,94,500 equity shares
- Equity consideration
- INR 9.18 Cr.
- CCDs allotted
- 2,41,05,500 Compulsory Convertible Debentures
- CCD consideration
- INR 24.62 Cr.
- Stake held post-allotment
- Dr. Rajendra Gadikota 20% (fully diluted basis)
Aurobindo's step-down arm A1 Biochem Labs allots shares and CCDs worth INR 33.80 crore, Apitoria stake down to 80%.
Agreement date
Allotment completed
Also from Aurobindo Pharma
USFDA final approval received for Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg
3 Oct 2026
Subsidiary completes acquisition of A1 Biochem Group's contract research business
2 Oct 2026
Aurobindo arm A1 Biocheme USA Inc completes 100% acquisition of A1 Biocheme Labs LLC for USD 15.247 Mn
2 Oct 2026
More numbers
- Consideration for equity sharesINR 9.18 Cr.
- Consideration for CCDsINR 24.62 Cr.
- Equity shares allotted89,94,500 equity shares
- CCDs allotted2,41,05,500 Compulsory Convertibles Debentures
- Stake held by Dr. Rajendra Gadikota20% stake (on a fully diluted basis)
- Apitoria stake post allotment80% stake
Source: BSE · 1 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.